VA greater LOS angeles lenalidomide do

Active Awarded Last action

Contract number
36C26226N0312
Awardee
Awarding agency
Obligated
$3,480,000

Award facts

Contract value 100% obligated
$3,480,000.00 Current and potential, with all options
Completion date 77% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boca Raton, FL 33432, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · VA greater LOS angeles lenalidomide do MOD updating pricing $0
Original award $3,480,000

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 22, issued a BPA call to Exelan Pharmaceuticals Inc. on January 15, 2026, for Lenalidomide supply with a ceiling value of $3,480,000. The call is issued under the Veterans Integrated Service Network 22 Blanket Purchase Agreement for Lenalidomide products, a framework agreement established for oncology and hematologic malignancy treatment protocols across the VA healthcare system. Performance occurs in Boca Raton, Florida, with completion required by January 14, 2027. The call involves firm-fixed-price supply of Lenalidomide in various strengths and formulations. Exelan Pharmaceuticals, a foreign-owned pharmaceutical manufacturer and distributor headquartered in Boca Raton, performs substantially all work at its primary facility and operates as a prime contractor without major subcontractors. The call was issued on an unrestricted, fully open basis without set-aside designation.

Quick answers

Who was awarded contract 36C26226N0312?

36C26226N0312 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 15, 2026.

How much is contract 36C26226N0312 worth?

The government has obligated $3,480,000 on 36C26226N0312.

Is contract 36C26226N0312 an order under another contract?

Yes. 36C26226N0312 is a BPA call under 36F79720D0227-36C26226A0006, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26226N0312 competed?

The extent of competition for 36C26226N0312 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award